A phase 3 randomised double-blind parallel group 24 week study to evaluate efficacy and sagety of once daily empagliflozin 10mg and 25mg compared to placebo all administed as oral fixed dose

Project: Research

StatusFinished
Effective start/end date15/04/1320/02/14